CNS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
Author content - pending or complete - column |
Richard.Glen (talk | contribs) m Formatted Author Names |
||
| Line 52: | Line 52: | ||
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]] | |[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]] | ||
|Disease | |Disease | ||
|Riley Lochner (trainee) | |Riley Lochner (trainee); | ||
Shashi Shetty (mentor) | |||
|6/7/2022 | |6/7/2022 | ||
| | | | ||
| Line 118: | Line 119: | ||
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]] | |[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]] | ||
|Disease | |Disease | ||
|Laveniya Satgunaseelan | |Laveniya Satgunaseelan | ||
| | | | ||
| | | | ||
| Line 611: | Line 612: | ||
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]] | |[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]] | ||
|Disease | |Disease | ||
|Lisa Lansdon, PhD (LGG trainee just finished) | |Lisa Lansdon, PhD (LGG trainee just finished); | ||
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City | |||
|9/20/21 | |9/20/21 | ||
| | | | ||